Genomate Health: Nabil Hafez

Nabil Hafez has been appointed as CEO of Genomate Health as the Cambridge, Massachusetts-based precision oncology company embarks on its US launch and global scaling. Hafez joins Genomate from GenomOncology, where he served as VP of sales. He was previously VP of sales for PierianDx, and before that, he was senior director of product management and marketing at Sunquest Information Systems. Hafez has also worked for Quest Diagnostics and GenomeQuest. Genomate said that Hafiz's appointment marks a major milestone for the company, which was founded in 2022 as a spinout of Hungary's Oncompass Medicine.